Abstract:Cerebrovascular fragility and cerebral microhemorrhages (CMH) contribute to age-related cognitive impairment, mobility defects, and vascular cognitive impairment and dementia, impairing healthspan and reducing quality of life in the elderly. Insulin-like growth factor 1 (IGF-1) is a key vasoprotective growth factor that is reduced during aging. Circulating IGF-1 deficiency leads to the development of CMH and other signs of cerebrovascular dysfunction. Here our goal was to understand the contribution of IGF-1 signaling on vascular smooth muscle cells (VSMCs) to the development of CMH and associated gait defects. We used an inducible VSMC-specific promoter and an IGF-1 receptor (Igf1r) floxed mouse line (Myh11-CreERT2 Igf1rf/f) to knockdown Igf1r. Angiotensin II in combination with L-NAME-induced hypertension was used to elicit CMH. We observed that VSMC-specific Igf1r knockdown mice had accelerated development of CMH, and subsequent associated gait irregularities. These phenotypes were accompanied by upregulation of a cluster of pro-inflammatory genes associated with VSMC maladaptation. Collectively our findings support an essential role for VSMCs as a target for the vasoprotective effects of IGF-1, and suggest that VSMC dysfunction in aging may contribute to the development of CMH.

What problem does this paper attempt to address?

### The problems the paper attempts to solve This article aims to explore the role of the insulin - like growth factor 1 receptor (IGF - 1R) signaling pathway in vascular smooth muscle cells (VSMCs) in the development of hypertensive - induced cerebral microbleeds (CMH) and gait deficits. Specifically, by constructing a VSMC - specific Igf1r - knockdown mouse model, the researchers evaluated how the deletion of the IGF - 1R signaling pathway in VSMCs affects the development of CMH and its associated gait disorders. ### Background and research significance Cerebrovascular vulnerability and cerebral microbleeds (CMH) are important factors leading to cognitive dysfunction, motor function deficits, and vascular cognitive impairment and dementia in the elderly, which seriously affect the healthy lifespan and quality of life of the elderly. Insulin - like growth factor 1 (IGF - 1) is an important vascular - protective growth factor, and its level gradually decreases during the aging process. The lack of circulating IGF - 1 can lead to the development of CMH and other cerebrovascular dysfunctions. Therefore, understanding the role of the IGF - 1 signaling pathway in VSMCs is of great significance for revealing the mechanism of CMH occurrence. ### Research methods 1. **Animal models**: - Use an inducible VSMC - specific Igf1r - knockdown mouse model (Myh11 - CreERT2 Igf1rf/f). - Induce hypertension by the combination of Angiotensin II and L - NAME to induce CMH. 2. **Experimental design**: - Divide the mice into a control group and an Igf1r - knockdown group, and set up normal blood pressure and hypertensive conditions respectively. - Monitor the development of CMH through a neurological scoring system. - Conduct histological analysis to detect the number, size distribution, and location of CMH. - Evaluate the gait changes of mice through a gait analysis system. ### Main findings 1. **VSMC - specific Igf1r - knockdown accelerates the development of CMH**: - Igf1r - knockdown hypertensive mice showed neurological symptoms of CMH earlier than control hypertensive mice. - The number of CMH in Igf1r - knockdown mice tended to increase, but the difference did not reach statistical significance. - The morphological characteristics of CMH in Igf1r - knockdown mice showed that the number of small CMH (<5000 µm²) was larger, indicating that capillaries and small veins may be more likely to rupture under VSMC - specific Igf1r - knockdown conditions. 2. **Gait deficits**: - Igf1r - knockdown hypertensive mice showed earlier gait abnormalities. ### Conclusions The results of this study support the crucial role of VSMCs in the IGF - 1 - mediated vascular protection, suggesting that VSMC dysfunction may be one of the important reasons for the occurrence of CMH during the aging process. These findings provide a new perspective for further research on the role of the IGF - 1 signaling pathway in cerebrovascular diseases.

Vascular smooth muscle cell-specific Igf1r deficiency exacerbates the development of hypertension-induced cerebral microhemorrhages and gait defects

IGF1R deficiency in vascular smooth muscle cells impairs myogenic autoregulation and cognition in mice

Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype

The vasoprotective role of IGF-1 signaling in the cerebral microcirculation: prevention of cerebral microhemorrhages in aging

Endothelial deficiency of insulin-like growth factor-1 receptor (IGF1R) impairs neurovascular coupling responses in mice, mimicking aspects of the brain aging phenotype

Endothelial deficiency of insulin-like growth factor-1 receptor leads to blood-brain barrier disruption and accelerated endothelial senescence in mice, mimicking aspects of the brain aging phenotype

Endothelin-1-Induced Focal Cerebral Ischemia in the Growth Hormone/IGF-1 Deficient Lewis Dwarf Rat

Cerebral microhemorrhages impair gait coordination in mice

Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis

Insulin-Like Growth Factor-1 Differentially Modulates Glutamate-Induced Toxicity and Stress in Cells of the Neurogliovascular Unit

IGF-1 Differentially Modulates Glutamate-Induced Toxicity and Stress in Cells of the Neurogliovascular Unit

Impaired intracellular Ca 2+ signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice

Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis

Abstract TP127: Hypertension Provokes Development Of Cerebral Microhemorrhages In A Mouse Model

Igf-1 Deficiency Resists Cardiac Hypertrophy and Myocardial Contractile Dysfunction: Role of Microrna-1 and Microrna-133a

Microvascular smooth muscle cells exhibit divergent phenotypic switching responses to platelet-derived growth factor and insulin-like growth factor 1

MYPT1SMKO Mice Function As a Novel Spontaneous Age- and Hypertension-Dependent Animal Model of CSVD

Targeting IGF1R signaling for brain aging and Alzheimer’s disease

Cardiac-specific Overexpression of Insulin-Like Growth Factor 1 Attenuates Aging-Associated Cardiac Diastolic Contractile Dysfunction and Protein Damage.

Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging

MFG-E8 mediates arterial aging by promoting the proinflammatory phenotype of vascular smooth muscle cells